Zobrazeno 1 - 4
of 4
pro vyhledávání: '"CHEK2, Checkpoint kinase 2"'
Publikováno v:
Advanced Drug Delivery Reviews
Graphical abstract
Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conven
Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76811ce2af0ea0f7b3342230007c3c01
https://doi.org/10.1016/j.addr.2021.03.018
https://doi.org/10.1016/j.addr.2021.03.018
Autor:
Kaidonis, Georgia, Pekmezci, Melike, Van Ziffle, Jessica, Auguste, Kurtis I, Horton, Jonathan C
Publikováno v:
Journal of neurosurgery. Case lessons, vol 3, iss 23
BACKGROUND In the past decade, next-generation sequencing has spurred significant progress in the understanding of cytogenetic alterations that occur in meningiomas. Eighty percent of adult meningiomas harbor pathogenic somatic variants involving NF2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44f43346690f3db1716396b938997aca
https://doi.org/10.3171/case2247
https://doi.org/10.3171/case2247
Publikováno v:
British Journal of Cancer
Germline mutations in both BRCA2 and CHEK2 are associated with an increased risk for male breast cancer. To search for potential interactions between the products of these breast cancer susceptibility genes, we undertook systematic mapping of BRCA2 f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa6783b677bab2b309298ebfad388ca9
https://doi.org/10.1038/sj.bjc.6604644
https://doi.org/10.1038/sj.bjc.6604644
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.